top of page

Psychedelic Medicine with Jeannie Fontana

Conversations With Coleman

Mar 21, 2023

Dr. Jeannie Fontana talks to Coleman Hughes about her vision for a statewide initiative that would create a $5 billion funding agency for psychedelic research, proven highly effective for conditions like PTSD and Depression.

My guest today is Jeannie Fontana. Jeannie is the CEO of the TREAT California Initiative. TREAT is a statewide initiative that would create a $5 billion funding agency for psychedelic research, which has proven highly effective for conditions like PTSD and Depression. Jeannie was a founding member of the California Institute for Regenerative Medicine, which performs stem cell research. She has also advocated on behalf of patients with Lou Gehrig's disease. 

Jeannie and I talk about her background in medicine, toxicology and biochemistry. We talk about how she got into psychedelic research and doing psychedelics herself. I talk about my own experiences with psychedelic drugs, and much more.

TREAT California
  • Threads
  • X
  • Youtube
  • Instagram
  • Facebook
  • LinkedIn

DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE OR REFERRALS

No material on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. The information on this website is for educational and informational purposes only and does not constitute providing medical advice or professional services. Do not use the information provided for diagnosing or treating a health problem or disease. Those seeking personal medical advice should consult with a licensed physician or other qualified healthcare provider. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

At this time in the United States, ketamine is the only legal psychedelic medicine.

Neither TREAT California, Be HERD Foundation, nor their employees, nor any contributor to this website, makes any representations, express or implied, with respect to the information provided herein or to its use.

bottom of page